#Bersil

[gifseafins]

.

BRAZIL: RED LIKE EMBER

For those who don't know, this is the famous Pau Brasil. The word “Brazil” means “red as ember”. In the past, the species was known as ibirapitanga in Tupi-Guarani, where “ybirá” means “tree” and “pintanga” means “red”.

When settlers invaded our country, they referred to the tree as “bersil”, which meant “ember” at the time. Gradually, it ended up being called Pau-Brasil, but it is also known as pau-vermelho, pau-de-pernambuco, arabutã, ibirapitã, muirapiranga, orabutã, pau-rosado and pau-de-ink.

The red color is characteristic of the species, hence the name Brazil, as it refers to the color of embers.

The resin of the tree has an intense reddish color. It is probably for this reason that the species was named Pau-Brasil, due to its origin in the word ember (bersil), which refers to the earthy and reddish tones of its bark and resin.

.

BRASIL: VERMELHO COMO BRASA

Para quem não conhece, esse é o famoso Pau Brasil. A palavra “Brasil” significa “vermelho como brasa”. Antigamente, a espécie era conhecida como ibirapitanga em tupi-gurani, onde “ybirá” significa “árvore” e “pintanga” representa “vermelho”.

Quando os colonizadores invadiram o nosso país, eles se referiram à árvore como “bersil”, que significava “brasa” na época. Aos poucos, ela acabou sendo chamada de Pau-Brasil, mas também é conhecida como pau-vermelho, pau-de-pernambuco, arabutã, ibirapitã, muirapiranga, orabutã, pau-rosado e pau-de-tinta.

A coloração vermelha é própria da espécie, por isso o nome de Brasil, pois refere-se à cor de brasa.

A resina da árvore possui uma intensa cor avermelhada. Provavelmente deve ser por esse motivo que a espécie recebeu o nome de Pau-Brasil, pela origem na palavra brasa (bersil), que remete aos tons terrosos e avermelhados de sua casca e de sua resina.

[strictlyfavorites]

For those who do not know, this is the famous Brazil stick. The word “Brazil” means “red as hot”. In the past, it was called ibirapitanga in tupi-gurani, where "ybirá" means "tree" and "pintanga" represents "red". When the colonizers discovered our country, they referred to the tree as “bersil”, which meant “ember” at the time. Gradually, it ended up being called pau-brasil, but it is also known as pau-vermelho, pau-de-pernambuco, arabutã, ibirapitã, muirapiranga, orabutã, rosewood and pau-de-Tinta.

The red color is typical of the species, which is why the name of Brazil, because it refers to the color of embers.

The tree's resin has an intense reddish color. It is probably for this reason that the tree received the name of brazilwood, for its origin in the word brasa (bersil), which refers to the earthy and reddish tones of its bark and its resin.

The tree gained importance for the Portuguese because of its wood, which could be used in the construction of numerous objects (such as furniture and boxes), but mainly because the wood resin was used to produce dye used to dye fabrics.

[coldfront-courier]

 So um, yeah

fuck consistency, i’m gonna write down shit about my fan!lair of fr dragon’s i’ve been piecing together for a while now

The citadel of Stormcatcher‘s Mimic is a stronghold carved into the side of one of the huge walls of the of the carrion canyon, a somewhat loosely affiliated clan coming together mostly out of necessity, and forming bonds almost haphazardly. It was founded by it’s three rulers, Veni, Atosar, and Bersile, and maintains an alliance to no deity.

Bersile Windword, the last of the founders, she was only fully convinced to help the other’s settle when she realized the scope of what they were planning. Bersile is the only one that is mostly concerned with the citadel’s potential, often taking a more neutral stance on personal issues. She is said to be colder than the others, but can be a very generous patron, if properly pursued.

Veni Luna, the primary founder, was a long-running follower of a pack of shadow mirrors for most of her life, when their leader turned against them for seemingly no reason, shattering her ability to trust for some time. to the point where she isolated herself from dragon society entirely. When she stumbled upon an injured Atosar Bato along the edges of the hewn city, the sense of companionship she had thought lost long ago began to reform, and she could not let the nocturne recover alone. The least practical of the founders, Veni is often thought to be air-headed and dreamy, but inhonest dragons often find themselves on the wrong side of her fangs.

Atosar Bato originally became involved in Stormcatcher’s Mimic when they jokingly mentioned the idea to Veni as the two of them lay sheltered in the carrion canyon, only to find the mirror all too intrigued by the idea. Slowly, the two of them carved out a living in the hidden depths of the canyon, but it wasn’t until Atosar Bato convinced the much larger Bersile to help them carve dens into the rock itself that Stormcatcher’s Mimic truly became a reality. Atosar Bato is often the pragmatic one holding down the other founder’s loftier goals, the most likely to deny ideas, and the often the strongest voice among the three of them.

[desviesennoiretblanc]

Le mot “brésiller” n’est jamais parvenu à mes oreilles, mais je me souviens avoir entendu, dans nos campagnes samariennes, le mot “bersiller”.

Bersiller est un mot du patois picard. Il a le même sens que brésiller. C’est écrit ici.

[industrygrowth]

Intra-Uterine Contraceptive Devices Market Expected to Secure Prominent Revenue Share during 2021 to 2030

In a recent published report, Kenneth Research has updated the Intra-Uterine Contraceptive Devices Market report for for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.

U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4  billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Intra-Uterine Contraceptive Devices Market products.

Get a Sample PDF of report-https://www.kennethresearch.com/sample-request-10343162

According to the statistics by the World Bank, the current health expenditure (% of GDP) around the world increased from 9.08% in 2001 to 9.84% in 2018. Additionally, the current health expenditure per capita (current US$) increased from USD 492.99 in 2001 to USD 1110.84 in 2018. Moreover, growing concern for deaths caused due to various diseases and the need for treatment that can lower the crude death rate, which in the year 2019 recorded close to 7% (per 1000 people), are also anticipated to drive the market growth during the forecast period.

The report offers detailed coverage of Intra-Uterine Contraceptive Devices industry and main market trends with impact of coronavirus. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Intra-Uterine Contraceptive Devices by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

First, this report covers the present status and the future prospects of the global Intra-Uterine Contraceptive Devices market for 2015-2024. And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru]. At the same time, we classify Intra-Uterine Contraceptive Devices according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Request for Full Report: -https://www.kennethresearch.com/sample-request-10343162

Market Segment as follows: By Region *Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia] *Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland] *North America[United States, Canada, Mexico] *Middle East & Africa[GCC, North Africa, South Africa] *South America[Brazil, Argentina, Columbia, Chile, Peru]

Key Companies *Bayer AG *Teva Pharmaceuticals Industries *Mona Lisa N.V. *DKT International *Egemen International *Melbea AG *Ocon Medical Ltd. *Pregna International Limited *Medical Engineering Corporation SA *SMB Corporation and Meril Life Sciences Pvt. Ltd. *Medu Scientific Ltd, China RH Contraceptives Co., Ltd *Sanghai Jolly Medical Education Co., Ltd *Bernstein Leibhard LLP *Zheijang Daji Medical Instruments, Ltd. *Nimble International *AME Line, Technico *Cepeo *Contraceptivos *Injeflex Ind And Com Ltda *Bersil *Amed

Market by Type *Copper IUCD *Hormonal IUCD

Market by Application *Hospitals *Gynaecology clinics *Community healthcare

[crispyobjecttiger]

Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Due to the pandemic, we have included a special section on the Impact of COVID 19 on the Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version) 2020-2026 which would mention How the Covid-19 is Affecting the Industry, Market Trends and Potential Opportunities in the COVID-19 Landscape, Key Regions and Proposal for Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version) Players to battle Covid-19 Impact.

Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version) 2020-2026The

Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version) 2020-2026

report is one of the most comprehensive and important data about business strategies, qualitative and quantitative analysis of Global Market. It offers detailed research and analysis of key aspects of the Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version). The market analysts authoring this report have provided in-depth information on leading growth drivers, restraints, challenges, trends, and opportunities to offer a complete analysis of the Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version).

Top Leading players covered in the Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version) report : ​​​​​​​​​​​ Bayer AG Teva Pharmaceuticals Industries Mona Lisa N.V. DKT International Egemen International Melbea AG Ocon Medical Ltd. Pregna International Limited Medical Engineering Corporation SA SMB Corporation and Meril Life Sciences Pvt. Ltd. Medu Scientific Ltd, China RH Contraceptives Co., Ltd Sanghai Jolly Medical Education Co., Ltd Bernstein Leibhard LLP Zheijang Daji Medical Instruments, Ltd. Nimble International AME Line, Technico Cepeo Contraceptivos Injeflex Ind And Com Ltda Bersil Amed and More...

Get PDF Sample Report With Impact of COVID-19 on Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version)@

https://www.mraccuracyreports.com/marketreports/7/405/Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

The report offers clear guidelines for players to cement a position of strength in the global Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version). It prepares them to face future challenges and take advantage of lucrative opportunities by providing a broad analysis of market conditions. the global Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version) will showcase a steady CAGR in the forecast year 2020 to 2026.

Market Segment by Type covers: Copper IUCD Hormonal IUCD

Market Segment by Application covers: Hospitals Gynaecology clinics Community healthcare

Our Complimentary Sample Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version) Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology.

Inquire and Get Up to 30% Discount By Clicking Here!  

https://www.mraccuracyreports.com/marketreports/7/405/Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Regions Covered in the Global Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version):

• The Middle East and Africa (GCC Countries and Egypt)

• North America (the United States, Mexico, and Canada)

• South America (Brazil etc.)

• Europe (Turkey, Germany, Russia UK, Italy, France, etc.)

• Asia-Pacific (Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

Years Considered to Estimate the Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version) Size:

History Year: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2020-2026

Highlights of the Report:

• Accurate market size and CAGR forecasts for the period 2019-2026

• Identification and in-depth assessment of growth opportunities in key segments and regions

• Detailed company profiling of top players of the global Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

• Exhaustive research on innovation and other trends of the global Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

• Reliable industry value chain and supply chain analysis

• Comprehensive analysis of important growth drivers, restraints, challenges, and growth prospects

For Free Download Report:

https://www.mraccuracyreports.com/request/download/7/405/Intra-Uterine Contraceptive Devices Market Status and Trend Analysis 2017-2026 (COVID-19 Version)

Reasons to buy:

Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.

Recognize emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.

Classify potential new clients or partners in the target demographic.

Develop tactical initiatives by understanding the focus areas of leading companies.

Plan mergers and acquisitions meritoriously by identifying Top Manufacturer.

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope.

Report will be updated with the latest data and delivered to you within 2-4 working days of order.

Suitable for supporting your internal and external presentations with reliable high quality data and analysis.

Create regional and country strategies on the basis of local data and analysis.

Customization of the Report: MR Accuracy Reports provides customization of reports as per your need. This report can be personalized to meet your requirements. Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.

Contact Us: Mr. Marcus Kel Call: +1 804 500 1224 / +44 741841 3666 (International) +91 7405728100 (ASIA) Email: sales@mraccuracyreports.com Website: ww

[researchkraft19]

Intra-Uterine Contraceptive Devices Market 2020 Business Opportunities and Forecast to 2027

The market study on the global market for Intra-Uterine Contraceptive Devices examines current and historical values and provides projections based on accumulated database. The report examines both key regional and domestic markets to provide a conclusive analysis about the developments in the Intra-Uterine Contraceptive Devices market over the forecast period.

Get Free Research Summary of the Report@ https://www.researchkraft.com/request-sample/1075508

The Global Intra-Uterine Contraceptive Devices market report provides a systematic picture of the sector by way of study, synthesis, and summary of info originated from different sources. The experts have provided the various sides of the sector with a particular goal on identifying the major manipulators of the sector. The Global Intra-Uterine Contraceptive Devices market report correspondingly comprises a detailed market & vendor landscape aside from a SWOT analysis of the major players.

Global Intra-Uterine Contraceptive Devices Market Fragmentation as follows:

Fragmentation by Type Analysis

Copper IUCD

Hormonal IUCD

Fragmentation by Application Analysis

Hospitals

Gynaecology clinics

Community healthcare

Fragmentation by Company Analysis

Bayer AG, Teva Pharmaceuticals Industries, Mona Lisa N.V., DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd China RH Contraceptives Co. Ltd, Sanghai Jolly Medical Education Co. Ltd, Bernstein Leibhard LLP, Zheijang Daji Medical Instruments Ltd., Nimble International, AME Line Technico, Cepeo, Contraceptivos, Injeflex Ind And Com Ltda, Bersil, Amed

Global Intra-Uterine Contraceptive Devices Market Regional analysis includes::

North America

Europe

China

Japan

Southeast Asia

India

Get this report at an attractive cost @ https://www.researchkraft.com/check-discount/1075508

The Global interest for Intra-Uterine Contraceptive Devices Market is gauge to report solid improvement driven by utilization in major developing markets. Area astute government strategy, advertise condition, serious scene, present patterns in the market, mechanical development, up and coming advances and the specialized advancement in related industry are immensely significant elements affecting the development of the market. Since more development open doors are relied upon to come up between 2020 to 2027 contrasted with a couple of years prior, it implies the fast pace of progress and is protected to state that the Intra-Uterine Contraceptive Devices market improvement status and future pattern is required to be promising over the world.

Make an Enquiry about this report @https://www.researchkraft.com/send-an-enquiry/1075508

About Us:

Customization of this Report: The report is customized to satisfy the customer's requirements. Please join to all our sales, who'll make sure you acquire a report which works for your needs.

Contact Us: 

Email: sales@researchkraft.com

[kapils2208-blog]

Global Intra-Uterine Contraceptive Devices Market | Global Trends and Forecast to 2024

Global Intra-Uterine Contraceptive Devices Market is expected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

Global Intra-Uterine Contraceptive Devices, By Product Type (Hormonal IUCD, Copper IUCD), By End-User (Hospitals, Gynecology Clinics, Community Healthcare), By Geography (North America, Europe, Asia-Pacific, South America, Rest of the World) –Industry Trends and Forecast to 2024.

 Get Sample Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-intra-uterine-contraceptive-devices-market

 Market Segmentation of the Report:

On the basis of product type:

·         Copper IUCD

·         Hormonal IUCD

On the basis of end users:

·         Hospitals

·         Gynecology clinics

·         Community healthcare

By Geography:

·         North America

·         South America

·         Europe

·         Asia-Pacific

·         Middle East and Africa

Avail 10% instant discount on this report mail us @ sopan.gedam@databridgemarketresearch.com

 Key Players:

The Global Intra-Uterine Contraceptive Devices Market is highly concentrated to a few big players and rest to local players who cater to domestic markets only. Bayer AG dominated the IUCD devices market accounting for a highest market share in 2016, followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. Some of the other players in this market include DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA and, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, ZheijangDaji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, InjeflexInd And Com Ltda, Bersil, Amed among others holds 34.0% of the IUCDdelivery market in 2016.

BAYER HEALTHCARE AG:

Founded in 1863 and headquartered in Leverkusen, Germany, Bayer AG is a provider of healthcare, nutrition, and high-technology materials and services. The company has three business segments, namely, HealthCare, Crop Science, and Material Science. The HealthCare segment offers a wide range of products under animal health, pharmaceuticals, consumer care, and medical care.

 Recent Developments:

In October 2016, Bayer AG has successfully concluded the European registration procedure to gain EUwide marketing authorization for its new low-dose levonorgestrel-releasing intrauterine system (LNGIUS). The product is named Kyleena and will be available in the market from 2017 January.

In September 2016, Bayer AG has successfully received FDA approval for its new low-dose levonorgestrel releasing intrauterine system (LNG-IUS) “Kyleena” The launch of this product in October in U.S.

 MONA LISA N.V.:

Mona Lisa N.V. was founded in 1996, and is a subsidiary for EurimPharmaheadquarterd in Germany. Prior to 1996 the company was known as Homesteel-Achel which was an exclusive sub-manufacturer for Organon from 1980 to 1996. Mona Lisa specializes in manufacturing class II and III medical devices used in the field of gynecology. Mona Lisa N.V products are Copper-Intrauterine-Devices (IUD), Aspiration needles and Consultation services / sub-manufacturing services.

 Key Drivers:

Some of the major factors driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancements and favorable insurance for IUCD’s.

·         The growing rate of unintended pregnancies has aided the increase in the adoption of contraceptive methods which is expected to drive the growth of the IUCD market.

·         The rising number of initiatives to promote the use of intra uterine contraceptive devices acts as a significant driver for this market.

·         Growing awareness of contraceptive one of the factors contributing to the growth of the market in Europe.

 Inquiry about this Report visit @ https://databridgemarketresearch.com/speak-to-analyst/?dbmr=global-intra-uterine-contraceptive-devices-market

 TABLE OF CONTENTS

1. INTRODUCTION

 1.1. OVERVIEW OF GLOBAL INTRA-UTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET

1.2. CURRENCY AND PRICING

1.3. LIMITATION

1.4. MARKETS COVERED

 2. MARKET SEGMENTATION

 2.1. MARKETS COVERED

2.2. GEOGRAPHIC SCOPE

2.3. YEARS CONSIDERED FOR THE STUDY

2.4. CURRENCY AND PRICING

2.5. RESEARCH METHODOLOGY

2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS

2.7. SECONDARY SOURCES

2.8. ASSUMPTIONS

 3. MARKET OVERVIEW

 3.1. DRIVERS

3.1.1. INCREASED RATE OF UNPLANNED PREGNANCIES

3.1.2. RISING NUMBER OF INITIATIVES UNDERTAKEN BY THE PRIVATE FIRMS

3.1.3. FAVOURABLE INSURANCE FOR IUCD’S

3.1.4. GROWING AWARENESS OF CONTRACEPTIVE

3.1.5. GROWING FUNDS AND GRANTS FOR IUCD PRODUCTS

3.1.6. TECHNOLOGICAL ADVANCEMENTS

 3.2. RESTRAINTS

3.2.1. HIGH COST OF TREATMENT

3.2.2. THREAT OF CAUSING PELVIC INFLAMMOTORY DISEASE (PID)

3.2.3. THREAT CAUSING EPICTAPIC PREGNANCY

3.2.4. CHANGES IN GOVERNMENT REGULATIONS

 4. EXECUTIVE SUMMARY

 5. PREMIUM INSIGHTS

 6. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE

 6.1. OVERVIEW

 7. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY

 7.1. OVERVIEW

 7.2. NORTH AMERICA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.2.1. U.S. INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.2.2. CANADA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.2.3. MEXICO INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.3. EUROPE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.3.1. GERMANY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.3.2. FRANCE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.3.3. ITALY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.3.4. U.K. INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.3.5. SWITZERLAND INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.3.6. NETHERLANDS INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.3.7. SPAIN INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.3.8. RUSSIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.3.9. BELGIUM INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.3.10. TURKEY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.4. APAC INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.4.1. CHINA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.4.2. SOUTH KOREA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.4.3. JAPAN INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.4.4. INDIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.4.5. THAILAND INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.4.6. SINGAPORE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.4.7. MALAYSIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.4.8. PHILIPPINES INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.4.9. AUSTRALIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.4.10. INDONESIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.5. SOUTH AMERICA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.5.1. BRAZIL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.5.2. COLOMBIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.5.3. ARGENTINA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

                 7.5.4. CHILE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.5.5. ECUADOR INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.5.6. URUGUAY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.5.7. PARAGUAY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES

 7.5.8. PERU INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.5.9. BOLIVIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.6. MEA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.6.1. EGYPT INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 7.6.2. SAUDI ARABIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

 8. GLOBAL INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY SHARE

 8.1. COMPANY SHARE ANALYSIS: GLOBAL

8.2. COMPANY SHARE ANALYSIS: NORTH AMERICA

8.3. COMPANY SHARE ANALYSIS: EUROPE

8.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC

8.5. COMPANY SHARE ANALYSIS: SOUTH AMERICA

8.6. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

 9. COMPANY PROFILES

 9.1. BAYER AG

   9.1.1. COMPANY OVERVIEW

 9.1.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)

 9.1.3. REVENUE ANALYSIS

 9.1.4. PRODUCT PORTFOLIO

 9.1.5. RECENT DEVELOPMENTS

 9.1.6. DATA BRIDGE ANALYSIS

 9.2. TEVA PHARMACEUTICAL INDUSTRIES LTD.

   9.2.1. COMPANY OVERVIEW

 9.2.2. REVENUE ANALYSIS

 9.2.3. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)

 9.2.4. PRODUCT PORTFOLIO

 9.2.5. RECENT DEVELOPMENTS

 9.2.6. DATA BRIDGE ANALYSIS

 9.3. ALLERGEN PLC

 9.3.1. COMPANY OVERVIEW

 9.3.2. REVENUE ANALYSIS

 9.3.3. PRODUCT PORTFOLIO

 9.3.4. RECENT DEVELOPMENTS

 9.3.5. DATA BRIDGE ANALYSIS

 9.4. DKT INTERNATIONAL

 9.4.1. COMPANY OVERVIEW

 9.4.2. REVENUE ANALYSIS

 9.4.3. PRODUCT PORTFOLIO

 9.5. SMB CORPORATION

 9.5.1. COMPANY OVERVIEW

 9.5.2. REVENUE ANALYSIS

 9.5.3. PRODUCT PORTFOLIO

 9.5.4. RECENT DEVELOPMENTS

 9.5.5. DATA BRIDGE ANALYSIS

 9.6. OCON MEDICAL LTD.

 9.6.1. COMPANY OVERVIEW

 9.6.2. REVENUE ANALYSIS

 9.6.3. PRODUCT PORTFOLIO

 9.6.4. RECENT DEVELOPMENTS

 9.6.5. DATA BRIDGE ANALYSIS

 9.7. MONA LISA N.V.

 9.7.1. COMPANY OVERVIEW

 9.7.2. REVENUE ANALYSIS

 9.7.3. PRODUCT PORTFOLIO

 9.7.4. RECENT DEVELOPMENTS

 9.8. MEDISAFE DISTRIBUTION INC.

 9.8.1. COMPANY OVERVIEW

 9.8.2. REVENUE ANALYSIS

 9.8.3. PRODUCT PORTFOLIO

 9.8.4. RECENT DEVELOPMENTS

 Read more about this Report visit @ https://databridgemarketresearch.com/reports/global-intra-uterine-contraceptive-devices-market/

 This Report Contains:

·         No of pages: 171

·         No of Figures: 46

·         No of Tables: 134

 Key Points:

Bayer AG dominated the IUCD market accounting largest market share followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. along with others such as include DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA and, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, ZheijangDaji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, InjeflexInd And Com Ltda, Bersil, Amed.

·         Copper IUD market is growing with the highest CAGR.

·         Globally HormonalIUD is driving the market with highest market share. However, Copper IUD is growing with highest CAGR.

·         North America is dominating the intra-uterine contraceptive devices market.

About Data Bridge Market Research:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

 Contact:

Data Bridge Market Research

Tel: +1-888-387-2818

Email: sopan.gedam@databridgemarketresearch.com

[data-bridge-market-research]

The Market of Global Intra-Uterine Contraceptive Devices Market is expected to reach USD 4,851.2 million by 2024 from USD 3,684.1 million in 2016, at a CAGR of 3.5% in the forecast period 2017 to 2024. The new market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.

The major factors driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancements and favourable insurance for IUCD’s.

Market Segmentation: Global Intra-Uterine Contraceptive Devices

The Global Intra-Uterine Contraceptive Devices Market is segmented on the basis of product type, end user, and geography.

The global intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

Key Drivers: Global Intra-Uterine Contraceptive Devices

Some of the major factors driving the market for Intra-Uterine Contraceptive Devices (IUCD), such as growing awareness of contraceptive, increased rate of unplanned pregnancies, rising number of initiatives undertaken by the private firms, technological advancements and favourable insurance for IUCD’s.

The growing rate of unintended pregnancies has aided the increase in the adoption of contraceptive methods which is expected to drive the growth of the IUCD market.

The rising number of initiatives to promote the use of intra uterine contraceptive devices acts as a significant driver for this market.

Growing awareness of contraceptive one of the factors contributing to the growth of the market in Europe.

Key Points: Global Intra-Uterine Contraceptive Devices Market

Bayer AG dominated the IUCD market accounting largest market share followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. along with others such as include DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA and, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP, ZheijangDaji Medical Instruments, Ltd., Nimble International, AME Line, Technico, Cepeo, Contraceptivos, InjeflexInd And Com Ltda, Bersil, Amed.

Copper IUD market is growing with the highest CAGR.

Globally HormonalIUD is driving the market with highest market share. However, Copper IUD is growing with highest CAGR.

North America is dominating the intra-uterine contraceptive devices market.

[kabarlapangan]

Guardiola Terpilih Sebagai Manajer Terbaik September 2017

Guardiola Terpilih Sebagai Manajer Terbaik September 2017 - Manajer Manchester City, Josep Guardiola, saat ini terpilih menjadi manajer terbaik pada periode bulan September 2017, setelah mereka mengantarkan The Citizens ke puncak klasemen sementara ajang Premier League. Josep Guardiola unggul atas manajer Manchester United, Jose Mourinho. (agen casino baccarat)

Josep Guardiola sukses mengantarkan Manchester City yang menyapu bersih empat laga ajang Premier League selama bulan September 2017 lalu. Manchester City saat ini terlihat cukup produktif karena mampu mengemas total 17 gol ke gawang lawan-lawannya.

Pada laga pertama, Manchester City berhasil menang dengan lima gol tanpa balas atas Liverpool, yang berada di Stadion Etihad. Setelah itu, giliran Watford yang harus dihajar dengan skor akhir 0-6 dan Crystal Palace dengan skor akhir 5-0.

Terakhir, Manchester City berhasil menang dengan skor akhir 1-0 atas Chelsea. Hasil itu sukses mengantarkan Manchester City berada pada posisi pertama dengan perolehan poin 19, unggul selisih gol dari Manchester United yang berada di posisi kedua.

Berkat performa impresif itu, Josep Guardiola berhasil menyisihkan manajer-manajer lainnya yang menjadi nomine dan peraih penghargaan, yakni Jose Mourinho, Mauricio Pochettino dari Tottenham Hotspur, dan Arsene Wenger dari Arsenal.

Ini adalah penghargaan kedua Josep Guardiola semenjak ia melatih Manchester City di musim panas 2016 lalu. Josep Guardiola terlihat lebih nyaman ketika memulai musim 2017-2018 ini, hal tersebut membuat tim asuhannya langsung menyapu bersil empat pertandingan dengan skor menakjubkan. Walau begitu, Manchester City memulai musim ini dengan hasil imbang.

Sempat dianggap belum bisa tampil konsisten, Manchester United malah sukses bertahan di posisi puncak klasemen dnegan hanya tertaut jumlah gol saja dari Manchester United. Bahkan Chelsea yang merupakan juara ajang Premier League di musim ini terlihat kesulitan untuk bisa mengejar raihan poin Manchester City.

Banyak pihak yang memprediksi bahwa Manchester City akan mudah merebut gelar juara ajang Premier League musim ini. Di ajang Liga Champions, Manchester City masih bertahan di posisi puncak grup dengan memenangkan beberapa pertandingan kualifikasi sebelumnya. Guardiola kabarnya masih akan berusaha untuk memperbaiki penampilan timnya saat berhadapan dengan Stoke City pekan ini.